Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2005
05/19/2005WO2005044305A2 Methods of therapy for solid tumors expressing the cd40 cell-surface antigen
05/19/2005WO2005044304A2 Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia
05/19/2005WO2005044303A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof
05/19/2005WO2005044294A2 Method of therapy for cancers expressing the cd40 antigen
05/19/2005WO2005044293A2 Compositions able to prevent neurodegenerative processes and methods of assaying the same
05/19/2005WO2005044200A2 Methods and compositions for treating mcp-1 related pathologies
05/19/2005WO2005044012A2 Method for the decontamination of biological tissue
05/19/2005WO2005033281A3 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
05/19/2005WO2005022160A3 Diagnosis and treatment of micobacterial infections
05/19/2005WO2005021713A8 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
05/19/2005WO2005016263A3 Compositions and methods for treating hyperimmune response in the eye
05/19/2005WO2005016111A9 Antibodies directed to parathyroid hormone (pth) and uses thereof
05/19/2005WO2005012361A3 Antibodies raised against colon carcinomas
05/19/2005WO2004106378A3 Method of treating corneal transplant rejection by using vegf antagonists
05/19/2005WO2004084798A3 Antigen-presenting complex-binding compositions and uses thereof
05/19/2005WO2004076489A8 Modified antibody
05/19/2005WO2004039244A3 Methods and kits for diagnosing tumorigenicity
05/19/2005WO2004024871A3 Antibodies and methods for generating genetically altered antibodies with high affinity
05/19/2005WO2004016764A3 eNOS MUTANTS USEFUL FOR GENE THERAPY
05/19/2005WO2003077858A3 Humanized antibodies that recognize beta amyloid peptide
05/19/2005WO2003029419A3 Three dimensional structure of crystalline grp94 binding domain, and its methods of use
05/19/2005WO2003014703A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
05/19/2005WO2003009815A3 Compositions and methods for modulating blood-brain barrier transport
05/19/2005US20050108780 Intracellular antibodies for a retrovirus protein
05/19/2005US20050107596 Immunoglobulin specific to kidney basement membrane protein for use in diagnosis, prevention and treatment of goodpasture syndrome
05/19/2005US20050107595 Antibodies (monoclonal, humanized) conjugated to antigrowth/cytotoxic agents (maytansinoids, calicheamicins); host cells; immunohistochemistry
05/19/2005US20050107594 Using ion exchange chromatography to isolate immunoglobulins from antibody preparation
05/19/2005US20050107592 Lipid binding protein 1
05/19/2005US20050107589 Membrane fusion protein for use as toole in the treatment and prevention of inflammatory bowel and autoimmune diseases
05/19/2005US20050107585 Signal-1/signal-2 bifunctional peptide inhibitors
05/19/2005US20050107327 Administration of an NPY receptor antagonist to decrease the expression of the NPY gene; control cholesterol, LDL cholesterol and triglyserides in blood, prevent development of atherosclerosis
05/19/2005US20050107321 FLK-1 is a receptor for vascular endothelial growth factor
05/19/2005US20050107319 Method of inhibiting factor B-mediated complement activation, and the uses thereof
05/19/2005US20050107314 Modulation of cd200 receptors
05/19/2005US20050107293 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
05/19/2005US20050107285 comprising an agent which inhibits Fc gamma RIIIb receptor activity, activation or expression; Rheumatoid Arthritis
05/19/2005US20050107256 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them
05/19/2005US20050106755 Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
05/19/2005US20050106728 Using gamma irradiation to decontaminate biofluids and materials
05/19/2005US20050106683 Antibodies specific for sclerostin and methods for increasing bone mineralization
05/19/2005US20050106682 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
05/19/2005US20050106680 Interferon-like protein Zcyto21
05/19/2005US20050106679 Leptin proteins
05/19/2005US20050106677 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
05/19/2005US20050106676 Novel proteins having hemolytic activity and genes encoding the protein
05/19/2005US20050106675 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/19/2005US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders
05/19/2005US20050106672 Neurotransmission associated proteins
05/19/2005US20050106670 Isolated human G-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human GPCR proteins, and uses thereof
05/19/2005US20050106667 Variant complementary determining regions for use in identifying antigen binding polypeptides; mimetics; direceted protein evolution
05/19/2005US20050106659 Membrane protein for use as tool in detection of modulators for diagnosis, prevention and treatment of neurological and/or psychiatric diseases
05/19/2005US20050106658 Remodeling and glycoconjugation of peptides
05/19/2005US20050106648 Immmunoglobulin specific to staphylococcal surface protein for use in diagnosis and prevention of bacterial infection; vaccine development; immunotherapy
05/19/2005US20050106647 Antibodies with increased affinities for anthrax antigens
05/19/2005US20050106644 Compositions and methods for the diagnosis and treatment of tumor
05/19/2005US20050106638 Immunoglobulin for use in diagnosis, prevention and treatment of fibrosis and scarring; antiscarring agents
05/19/2005US20050106634 Using L1 cell adhesion protein as tool in neurons, neural and/or neuronal progenitor cells for use in treatment of nervous system disorders
05/19/2005US20050106624 Concentrating low molecular weight peptides in the supernatant of serum-free cultured cells via cation exchangers; identifying tumor marker peptides and diagnosing cell proliferative disorders
05/19/2005US20050106620 Novel ovarian tumor antigen (OVR107) for use in diagnosis, prognosis, classification and imaging of cell proliferative disorders
05/19/2005US20050106614 Reagents and methods useful for detecting diseases of the prostate
05/19/2005US20050106611 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
05/19/2005US20050106601 Transgenic mouse whose somatic and germ cells express an Fkhsf transgene and mutants; immunomodulators
05/19/2005US20050106599 Nucleotide sequences coding secretfed protein for use as tools in generating antibodies for use in forensics, gene therapeutics and diagnostics and chromosome mapping
05/19/2005US20050106595 Expressed sequence tags and encoded human proteins
05/19/2005US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease
05/19/2005US20050106569 Using concentration of paraneoplastic neuronal antigen (MA2) as diagnostic/prognostic risk indicator of nervous system disorders
05/19/2005US20050106567 Nucleotide sequences coding tau protein for use as diagnostic tool in detection of alzheimer's and neurodegenerative disorders
05/19/2005US20050106563 Severe acute respiratory syndrome (SARS) coronaviral polypeptide for use in diagnosis, prevention and treatment of viral disease; viricides; genetic vaccines
05/19/2005US20050106222 Genetic engineering; gene expression; polypeptides
05/19/2005US20050106163 Bovine immunization of new born calf against enteric disease
05/19/2005US20050106161 Vaccine ; human leukemia, lymphoma virus
05/19/2005US20050106159 Immunology efficiengy against Campylobacter; forming monoclonal antibodies; polypeptides
05/19/2005US20050106154 GASP1: a follistatin domain containing protein
05/19/2005US20050106153 mixture of immunoadjuvant in neoplasm; applying stresses to destroy neoplastic tissue; administering immunomoderator ; in situ generation of autologous vaccine
05/19/2005US20050106150 Restoring sensitivity to drug resistant tumor cells
05/19/2005US20050106149 Antibodies abolish prion propagation and remote clearance of infectivity
05/19/2005US20050106147 Method of promoting graft survival with anti-tissue factor antibodies
05/19/2005US20050106145 Anti-human tenascin monoclonal antibody
05/19/2005US20050106142 Rheumatic arthritis; hepatitis c virus; autoimmune diseases ; nterfering with forming or binding of such; autoantigen
05/19/2005US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof
05/19/2005US20050106139 Humanized tissue factor antibodies
05/19/2005US20050106138 Specific depletion of cd4+ t cells
05/19/2005US20050106136 Controlling capilalries, blood vessels in eye; vision defects
05/19/2005US20050106135 Compositions, kits and treating methods for alteration cell-cell adhesion, transport, or permeation properties of tissues
05/19/2005US20050106108 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
05/19/2005US20050106102 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/19/2005US20050106100 Diagnosis, detection, monitoring a pathology condition; chelate compound labeled with metalloproteinase; cardiovascular disorders; anticancer agents; antitumor agents; antiischemic agents
05/19/2005US20050106099 Fusion proteins
05/19/2005US20050103712 Immunoadsorbents are monoclonal or polyclonal antibodies affixed with solid support capable of a absorbing toxin released from infecting bacteria allowing removal of the toxin
05/19/2005DE10348319A1 Bindemoleküle für die Extra-Domäne B von Fibronectin zur Detektion von atherosklerotischen Plaques Binding molecules for the extra-domain B of fibronectin for detection of atherosclerotic plaques
05/19/2005DE10346627A1 Single-chain-Antikörper gegen den 37 kDa/67 kDa Lamininrezeptor als Werkzeuge zur Diagnose und Therapie von Prionerkrankungen und Krebs, deren Herstellung und Verwendung Single-chain antibody against the 37 kDa / 67 kDa laminin as tools for diagnosis and therapy of prion diseases and cancer, their preparation and use
05/19/2005CA2545166A1 Humanized anti-cd47 antibody
05/19/2005CA2545160A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
05/19/2005CA2544951A1 Use of antagonist anti-cd40 monoclonal antibodies for treatment of multiple myeloma
05/19/2005CA2544949A1 Antagonist anti-cd40 monoclonal antibodies and methods for their use
05/19/2005CA2544948A1 Methods of therapy for cancers expressing the cd40 antigen
05/19/2005CA2544924A1 Methods and compositions for treating mcp-1 related pathologies
05/19/2005CA2544865A1 Cd20 antibodies with increased fc receptor binding affinity and effector function
05/19/2005CA2544853A1 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases, and organ transplant rejection
05/19/2005CA2544852A1 Methods of therapy for solid tumors expressing the cd40 cell-surface antigen
1 ... 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 ... 1494